Global Neurointerventional Devices Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product;
Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic, Balloons, and Stent Retrievers.By Technique;
Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Neurointerventional Devices Market (USD Million), 2021 - 2031
In the year 2024, the Global Neurointerventional Devices Market was valued at USD 2,894.86 million. The size of this market is expected to increase to USD 4,694.33 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.2%.
The Global Neurointerventional Devices Market is poised for significant growth, driven by the increasing prevalence of neurological disorders and advancements in medical technology. Neurointerventional devices are minimally invasive tools used to diagnose and treat vascular diseases of the central nervous system, including stroke, cerebral aneurysms, and arteriovenous malformations. These devices offer an alternative to traditional surgical procedures, providing patients with safer, less invasive options that often result in shorter recovery times and improved outcomes.
The rising incidence of stroke and other cerebrovascular diseases is a major factor propelling the demand for neurointerventional devices. As the global population ages, the burden of these conditions is expected to increase, further driving market growth. In addition, advancements in imaging technologies and the development of innovative devices have enhanced the precision and efficacy of neurointerventional procedures, making them more widely adopted by healthcare professionals.
Technological innovations, such as the development of next-generation stents, coils, and thrombectomy devices, are transforming the landscape of neurointerventional treatments. These advancements enable more effective management of complex neurovascular conditions, reducing the risk of complications and improving patient outcomes. The integration of artificial intelligence and robotics in neurointerventional procedures is opening new frontiers in the market, offering enhanced precision and control during interventions.
The market is experiencing dynamic growth fueled by technological advancements, increasing prevalence of neurological disorders, and a shift towards minimally invasive treatment options. As the market continues to evolve, it presents numerous opportunities for innovation and investment, ultimately aiming to enhance patient care and outcomes in the field of neurovascular interventions.
Global Neurointerventional Devices Market Recent Developments
-
In 2023, Medtronic introduced its latest neurointerventional device, the Solitaire™ Prime Revascularization Device, a next-generation stentriever aimed at enhancing stroke treatment.
-
In 2023, Stryker announced the acquisition of Neurovascular Therapies, a leading producer of neurointerventional devices. This acquisition allows Stryker to expand its portfolio of neurointerventional devices by incorporating Neurovascular Therapies' products.
-
In 2022, Terumo launched its new neurointerventional device, the Wingspan® Stent System. This self-expanding intracranial stent is designed to treat stenosis in the intracranial arteries.
Segment Analysis
This report extensively covers different segments of Global Neurointerventional Devices Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
The market has been segmented by product, technique, and geography, offering a comprehensive understanding of the diverse elements driving this dynamic market. By product, the market encompasses a variety of devices critical to neurointerventional procedures. These products include embolization devices, thrombectomy devices, stenting systems, and neurovascular catheters, among others. Each category plays a specific role in the diagnosis and treatment of neurovascular conditions, enabling healthcare providers to manage and treat complex neurological disorders with greater precision and efficacy.
The segmentation by technique highlights the different approaches employed in neurointerventional procedures. Techniques such as endovascular coiling, flow diversion, and mechanical thrombectomy represent the forefront of minimally invasive treatment options. These techniques are continually evolving, driven by technological innovations and clinical research aimed at improving patient outcomes.
Geographically, the market is segmented into five key regions: North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America, provides a detailed framework for understanding the market's complexities and growth opportunities.
Global Neurointerventional Devices Segment Analysis
In this report, the Global Neurointerventional Devices Market has been segmented by Product, Technique, and Geography.
Global Neurointerventional Devices Market, Segmentation by Product
The Global Neurointerventional Devices Market has been segmented by Product into Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Devices, Flow Diverters Devices, Intrasaccular Devices, Liquid Embolic, Balloons, and Stent Retrievers.
Embolic coils are commonly used to treat cerebral aneurysms by promoting clot formation within the aneurysm sac, thus preventing rupture. These coils are made of soft platinum and are inserted into the aneurysm through a catheter, offering a minimally invasive alternative to surgical clipping. Carotid stents are employed to open narrowed carotid arteries, reducing the risk of stroke by improving blood flow to the brain. These stents are typically used in conjunction with embolic protection devices to capture any dislodged plaque during the procedure, enhancing patient safety and outcomes.
Intracranial stents serve a similar purpose within the brain's vasculature, providing structural support to weakened or narrowed blood vessels. These stents are crucial in the treatment of intracranial atherosclerotic disease and recurrent stroke prevention, offering an effective means of maintaining blood flow in critical areas of the brain. Neurovascular thrombectomy devices are designed to remove blood clots from the brain's arteries, addressing acute ischemic stroke. These devices, including stent retrievers and aspiration systems, allow for the rapid and effective restoration of blood flow, significantly improving the chances of recovery and reducing long-term disability.
Embolic protection devices are used during procedures such as carotid artery stenting to capture and remove debris that may be dislodged, preventing it from traveling to the brain and causing an embolic stroke. These devices enhance the safety of neurointerventional procedures, ensuring that any potential complications are minimized. Flow diverter devices are innovative tools used to treat complex and wide-necked cerebral aneurysms. They redirect blood flow away from the aneurysm, promoting healing and reducing the risk of rupture. Flow diverters are especially valuable for aneurysms that are not suitable for traditional coiling techniques.
Intrasaccular devices are inserted directly into the aneurysm sac, providing immediate support and promoting thrombosis within the aneurysm. These devices are used to treat both ruptured and unruptured aneurysms, offering an effective and minimally invasive treatment option. Liquid embolic agents are used to occlude abnormal blood vessels or vascular malformations. These agents are delivered through a microcatheter and solidify upon contact with blood, providing a flexible and precise method for treating a variety of neurovascular conditions.
Balloons play a versatile role in neurointerventional procedures, such as balloon angioplasty to dilate narrowed vessels or as adjuncts in stent placement. These devices can also be used in conjunction with embolic coils to assist in the occlusion of aneurysms by providing temporary flow diversion. Stent retrievers are a type of neurovascular thrombectomy device specifically designed to mechanically retrieve blood clots from the brain's arteries during acute ischemic stroke treatment. Their ability to restore blood flow quickly and efficiently makes them an essential tool in the management of stroke patients.
Global Neurointerventional Devices Market, Segmentation by Technique
The Global Neurointerventional Devices Market has been segmented by Technique into Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, and Flow Disruption.
Neurothrombectomy procedures are critical for the treatment of acute ischemic stroke, where rapid removal of a blood clot is essential to restore blood flow to the brain. Techniques such as mechanical thrombectomy, using devices like stent retrievers and aspiration catheters, allow for the efficient extraction of clots, significantly improving patient outcomes and reducing long-term disabilities associated with stroke.
Cerebral angiography is a diagnostic and interventional technique that involves imaging the blood vessels of the brain using contrast dye and X-rays. This procedure is crucial for identifying abnormalities such as aneurysms, arteriovenous malformations, and stenoses. It provides detailed visualization of the cerebral vasculature, guiding subsequent interventional procedures and ensuring precise treatment.
Stenting involves the placement of stents within the blood vessels of the brain to treat conditions such as intracranial stenosis and carotid artery disease. By expanding narrowed vessels, stenting improves blood flow and reduces the risk of stroke. The use of stents is often accompanied by embolic protection devices to capture debris and prevent embolic events during the procedure.
Coiling procedures are primarily used to treat cerebral aneurysms. During this minimally invasive technique, soft platinum coils are inserted into the aneurysm sac via a catheter. These coils promote clot formation, effectively sealing off the aneurysm and preventing rupture. Coiling is a preferred alternative to surgical clipping, offering a less invasive option with shorter recovery times.
Flow disruption techniques, such as the use of flow diverter devices, are employed to treat complex and wide-necked aneurysms. These devices are designed to redirect blood flow away from the aneurysm, reducing the pressure on the aneurysm wall and promoting natural healing. Flow disruption is particularly valuable for aneurysms that are difficult to treat with traditional coiling methods.
Global Neurointerventional Devices Market, Segmentation by Geography
In this report, the Global Neurointerventional Devices Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Neurointerventional Devices Market Share (%), by Geographical Region, 2024
North America leads the market, driven by advanced healthcare infrastructure, high prevalence of neurological disorders, and significant investments in research and development. The United States, in particular, contributes substantially to the market due to its strong network of specialized healthcare facilities and a growing number of neurointerventional procedures performed annually. Additionally, favorable reimbursement policies and ongoing clinical trials further bolster the region's market dominance.
Europe follows closely, with countries like Germany, France, and the United Kingdom playing pivotal roles. The region benefits from increasing healthcare expenditure and a rising focus on minimally invasive procedures. European countries are also actively involved in clinical research and technological innovations, contributing to the market's growth. The European Union's regulatory environment, which supports the approval and adoption of advanced medical devices, further accelerates market expansion.
Asia Pacific is expected to witness the highest growth rate in the coming years. The region's market growth is propelled by improving healthcare infrastructure, rising patient awareness, and a growing geriatric population susceptible to neurovascular disorders. Countries such as China, Japan, and India are investing heavily in healthcare advancements and expanding access to neurointerventional treatments. The increasing incidence of stroke and other cerebrovascular diseases in these countries drives the demand for innovative neurointerventional devices.
The Middle East and Africa region is gradually emerging as a significant market for neurointerventional devices. Improvements in healthcare infrastructure, coupled with rising investments in medical technology, are contributing to market growth. Countries like the United Arab Emirates and South Africa are leading the region in adopting advanced neurointerventional procedures. Efforts to increase awareness of neurovascular diseases and the availability of specialized medical care are further enhancing market prospects.
Latin America is also experiencing growth in the neurointerventional devices market. Brazil, Mexico, and Argentina are key contributors, driven by expanding healthcare services and increasing investment in medical technologies. The region's growing focus on minimally invasive procedures and the rising burden of neurological disorders are key factors propelling market expansion. Government initiatives to improve healthcare access and infrastructure are also playing a crucial role in the region's market development.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Neurointerventional Devices Market. These factors include; Market Drivers, Restraints, and Opportunities.
Drivers:
- Increasing neurological disorders
- Aging population
- Demand for minimally invasive procedures
-
Awareness of stroke treatments - Awareness of stroke treatments serves as a significant driver in the Global Neurointerventional Devices Market. As public and healthcare professional awareness about the symptoms and urgency of stroke treatment increases, the demand for effective and timely interventions grows. Educational campaigns, both governmental and non-governmental, have significantly contributed to this heightened awareness, emphasizing the importance of early detection and immediate medical response to stroke symptoms.
This increased awareness translates into a higher number of patients seeking medical help promptly, thus boosting the demand for neurointerventional devices. Hospitals and clinics are better equipped to perform neurointerventional procedures, such as thrombectomies, due to the rising number of trained specialists and the availability of advanced devices. Additionally, stroke awareness has led to the establishment of more specialized stroke centers, which are well-equipped with the necessary neurointerventional tools and staffed by trained professionals capable of providing rapid and effective treatment.
Awareness initiatives have underscored the critical time window for treating strokes, often referred to as the "golden hour," during which neurointerventional procedures can significantly improve patient outcomes. This understanding encourages quicker hospital admissions and the use of advanced imaging technologies to diagnose and treat strokes accurately. As a result, the market for neurointerventional devices is bolstered by an increased number of procedures performed within this crucial timeframe.
Restraints:
- Limited accessibility
- Regulatory hurdles
- Shortage of skilled professionals
-
Risk of complications - The risk of complications serves as a significant restraint in the Global Neurointerventional Devices Market. Despite the advancements in neurointerventional technology, these procedures carry inherent risks that can deter both patients and healthcare providers. Potential complications, such as bleeding, infection, or damage to blood vessels, can result in adverse outcomes, including worsening of the patient’s condition or even fatality. These risks are particularly concerning given the delicate nature of the brain and its vasculature, where even minor complications can lead to severe consequences.
Healthcare professionals must weigh the benefits of neurointerventional procedures against these potential risks, which can sometimes lead to hesitation or conservative treatment approaches. This caution can result in fewer procedures being performed, thereby limiting the market growth. Additionally, the fear of litigation related to medical complications further exacerbates this restraint, as practitioners may prefer traditional surgical methods or pharmacological treatments over neurointerventional techniques.
Complications can increase the cost of treatment due to the need for additional medical care and extended hospital stays. This financial burden can strain healthcare systems and insurance providers, potentially leading to stricter guidelines and approval processes for neurointerventional procedures. These financial and regulatory barriers further constrain the market’s growth.
Opportunities:
- Cost-effective devices
- AI and robotics integration
- Outpatient procedure growth
-
Bioresorbable stents - Bioresorbable stents present a significant opportunity in the Global Neurointerventional Devices Market. These innovative stents are designed to provide temporary support to blood vessels during the critical healing period and then gradually dissolve, reducing the long-term risks associated with permanent implants. This technology addresses several limitations of traditional metal stents, offering numerous benefits that could drive market growth.
One of the primary advantages of bioresorbable stents is the reduction in complications related to long-term implantation. Permanent stents can sometimes lead to issues such as chronic inflammation, late thrombosis, or restenosis. Bioresorbable stents, by dissolving after their job is done, minimize these risks, leading to better patient outcomes and increased acceptance among healthcare providers.
Bioresorbable stents align with the growing trend towards minimally invasive and patient-friendly treatments. Their ability to support vessel healing without leaving a permanent foreign object in the body makes them an attractive option for patients and physicians alike. This appeal is particularly strong in neurointerventional procedures, where the delicate nature of the brain's vasculature demands the safest possible interventions.
The development and adoption of bioresorbable stents also open up new avenues for innovation and competition within the market. Companies investing in this technology can differentiate themselves and capture market share by offering an solutions. Ongoing research and development can lead to improved designs and materials, further enhancing the efficacy and safety of these stents.
Competitive Landscape Analysis
Key players in Global Neurointerventional Devices Market include,
- Stryker Corporation
- Penumbra Inc.
- Covidien Public Limited
- Johnson & Johnson Private Limited
- Terumo Corporation
- Medtronic
- Boston Scientific
- MicroPort Scientific Corporation
- W. L. Gore & Associates, Inc.
- Abbott
- Philips Healthcare
- Siemens Healthineers
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technique
- Market Snapshot, By Region
- Global Neurointerventional Devices Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing neurological disorders
- Aging population
- Demand for minimally invasive procedures
- Awareness of stroke treatments
- Restraints
- Limited accessibility
- Regulatory hurdles
- Shortage of skilled professionals
- Risk of complications
- Opportunities
- Cost-effective devices
- AI and robotics integration
- Outpatient procedure growth
- Bioresorbable stents
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Neurointerventional Devices Market, By Product, 2021 - 2031 (USD Million)
- Embolic Coils
- Carotid Stents
- Intracranial Stents
- Neurovascular Thrombectomy
- Embolic Protection Devices
- Flow Diverters Devices
- Intrasaccular Devices
- Liquid Embolic
- Balloons
- Stent Retrievers
- Global Neurointerventional Devices Market, By Technique, 2021 - 2031 (USD Million)
- Neurothrombectomy Procedure
- Cerebral Angiography
- Stenting
- Coiling Procedures
- Flow Disruption
- Global Neurointerventional Devices Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Neurointerventional Devices Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Stryker Corporation
- Penumbra Inc.
- Covidien Public Limited
- Johnson & Johnson Private Limited
- Terumo Corporation
- Medtronic
- Boston Scientific
- MicroPort Scientific Corporation
- W. L. Gore & Associates, Inc.
- Abbott
- Philips Healthcare
- Siemens Healthineers
- Company Profiles
- Analyst Views
- Future Outlook of the Market